Houlihan Lokey, Inc. (NYSE: HLI) is a Financial Services company in the Investment - Banking & Investment Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 21.94 | EPS (ttm) | 5.95 | Insider Own | 6.16% | Shs Outstand | 69.89M | Perf Week | -4.44% |
| Market Cap | 9.13B | Forward P/E | 15.03 | EPS next Y | 8.69 | Insider Trans | -0.09% | Shs Float | 69.78M | Perf Month | 0.35% |
| Enterprise Value | 8.82B | PEG | 1.21 | EPS next Q | 1.60 | Inst Own | - | Short Float | 3.64% | Perf Quarter | -7.26% |
| Income | 407.00M | P/S | 3.62 | EPS this Y | 16.57% | Inst Trans | - | Short Ratio | 3.00 | Perf Half Y | -6.05% |
| Sales | 2.52B | P/B | 3.86 | EPS next Y | 25.22% | ROA | 10.93% | Short Interest | 2.54M | Perf YTD | -25.05% |
| Book/sh | 33.84 | P/C | 11.45 | EPS next 5Y | 18.17% | ROE | 17.78% | 52W High | 211.79 -38.36% | Perf Year | -36.13% |
| Cash/sh | 11.40 | P/FCF | 19.70 | EPS past 3/5Y | 18.27% 6.45% | ROIC | 13.70% | 52W Low | 112.83 15.71% | Perf 3Y | 21.21% |
| Dividend Est. | 2.80 (2.14%) | EV/EBITDA | 14.82 | Sales past 3/5Y | 13.11% 11.41% | Gross Margin | 50.80% | Volatility | 3.15% 2.89% | Perf 5Y | 47.10% |
| Dividend TTM | 2.60 (1.99%) | EV/Sales | 3.50 | EPS Y/Y TTM | 2.23% | Oper. Margin | 21.82% | ATR (14) | 4.36 | Perf 10Y | 428.33% |
| Dividend Ex-Date | Sep 01, 2026 | Quick Ratio | 1.44 | Sales Y/Y TTM | 5.61% | Profit Margin | 16.10% | RSI (14) | 45.05 | Recom | 2.47 |
| Dividend Gr. 3/5Y | 5.47% 13.11% | Current Ratio | 1.44 | EPS Q/Q | -31.12% | SMA20 | -1.93% | Beta | 1.00 | Target Price | 163.60 |
| Payout | 44.95% | Debt/Eq | 0.20 | Sales Q/Q | -15.54% | SMA50 | -1.87% | Rel Volume | 2.17 | Prev Close | 132.66 |
| Employees | 2,800 | LT Debt/Eq | 0.20 | Earnings | Oct 29 | SMA200 | -14.09% | Avg Volume | 897.69K | Price | 130.55 |
| IPO Date | Aug 13, 2015 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -17.90% -15.17% | Net Debt/EBITDA | -0.42 | Volume | 1,951,494 | Change | -1.59% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-03-26 | Reiterated | BMO Capital | Outperform | $211 → $145 |
| Jul-30-26 | Reiterated | Morgan Stanley | Overweight | $193 → $177 |
| Jul-30-26 | Reiterated | Goldman Sachs | Buy | $164 → $148 |
| Jul-10-26 | Initiated | BofA | Buy | $164 |
| Jul-09-26 | Reiterated | US Capital Advisors | $193 → $187 | |
| Jul-08-26 | Reiterated | UBS | Neutral | $160 → $161 |
| May-07-26 | Reiterated | UBS | Neutral | $163 → $160 |
| Apr-09-26 | Reiterated | Morgan Stanley | Overweight | $163 → $193 |
| Jan-30-26 | Reiterated | UBS | Buy | $193 → $196 |
| Jan-29-26 | Reiterated | BMO Capital | Outperform | $211 |
Houlihan Lokey, Inc. is a prominent global investment banking firm offering a comprehensive suite of financial advisory services. These include expertise in mergers and acquisitions (M&A), capital markets, financial restructuring, and valuation. The company's operations are divided into three core segments: The Corporate Finance division provides broad financial guidance. It assists both public and private entities with strategic buy-side and sell-side transactions and a variety of capital-raising activities, such as leveraged loans, private mezzanine debt, high-yield debt, initial public offerings (IPOs), follow-on offerings, convertibles, equity private placements, and private equity investments. This segment also advises financial sponsors on diverse deal structures and liability management initiatives. The Financial Restructuring segment guides debtors, creditors, and other involved parties through complex recapitalization and deleveraging processes. Its specialized advisory services encompass the design, negotiation, and confirmation of reorganization plans, the structuring and analysis of exchange offers, corporate viability assessments, expert testimony for dispute resolution, and the procurement of debtor-in-possession (DIP) financing. The Financial and Valuation Advisory group specializes in appraising various asset types, including entire businesses, illiquid debt and equity securities, and intellectual property. It delivers critical fairness opinions for M&A and other transactions, as well as solvency opinions for corporate spin-offs and dividend recapitalizations, alongside other financial assessments. This segment further contributes to dispute resolution services. Established in 1972, Houlihan Lokey serves a diverse clientele, including corporations, institutions, and governmental entities. Headquartered in Los Angeles, California, the firm maintains a significant international presence with offices located across the United States, Europe, the Middle East, and the Asia-Pacific region.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2026 3/31/2026 | FY 2025 3/31/2025 | FY 2024 3/31/2024 | FY 2023 3/31/2023 | FY 2022 3/31/2022 | FY 2021 3/31/2021 | FY 2020 3/31/2020 | FY 2019 3/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,523 | 2,618 | 2,389 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,241 | 43 | 1,469 | — | — | — | — | — | — | |
| Gross Profit | 1,282 | 2,575 | 920 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 79 | 0 | 188 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 653 | 1,956 | 230 | — | — | — | — | — | — | |
| Operating Income | 550 | 619 | 502 | — | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 0 | -56 | 30 | — | — | — | — | — | — | |
| Net Income Before Taxes | 551 | 562 | 531 | — | — | — | — | — | — | |
| Income Taxes | 145 | 138 | 132 | — | — | — | — | — | — | |
| Consolidated Net Income | 407 | 426 | 400 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 405 | 424 | 400 | — | — | — | — | — | — | |
| Net Income | 407 | 426 | 400 | — | — | — | — | — | — | |
| EPS (Recurring) | 6.09 | 6.40 | 6.08 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 6.09 | 6.40 | 6.08 | — | — | — | — | — | — | |
| EPS (Diluted) | 5.95 | 6.22 | 5.82 | — | — | — | — | — | — | |
| EBITDA | 595 | 605 | 598 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 21.94 | 23.09 | 27.75 | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.47 | 3.68 | 4.46 | — | — | — | — | — | — | |
| Gross Margin | 50.81 | 98.36 | 38.51 | — | — | — | — | — | — | |
| Operating Margin | 21.80 | 23.64 | 21.01 | — | — | — | — | — | — | |
| Net Margin | 16.13 | 16.27 | 16.74 | — | — | — | — | — | — | |
| Shares Outstanding | 67 | 67 | 66 | — | — | — | — | — | — | |
| Market Capitalization | 8,747 | 9,623 | 10,659 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| CRAIN CHRISTOPHER M | GENERAL COUNSEL | Sep 10 '26 | Sale | 140.15 | 1,000 | 140,150 | 0 | Sep 10 |
| ALLEY J LINDSEY | Chief Financial Officer | Aug 03 '26 | Buy | 124.52 | 4,020 | 500,570 | 4,020 | Aug 05 |
| BEISER SCOTT L | CO-CHAIRMAN | May 21 '26 | Sale | 150.26 | 6,265 | 941,379 | 0 | May 21 |
| CRAIN CHRISTOPHER M | GENERAL COUNSEL | Apr 01 '26 | Sale | 143.40 | 500 | 71,700 | 0 | Apr 02 |
| SCHRIESHEIM ROBERT A | Director | Feb 06 '26 | Sale | 170.86 | 5,000 | 854,300 | 27,982 | Feb 10 |
| CRAIN CHRISTOPHER M | GENERAL COUNSEL | Jan 02 '26 | Sale | 174.17 | 500 | 87,085 | 0 | Jan 05 |
| GOLD IRWIN | CO-CHAIRMAN | Sep 16 '25 | Sale | 202.75 | 6,811 | 1,380,930 | 0 | Sep 18 |
| CRAIN CHRISTOPHER M | GENERAL COUNSEL | Sep 02 '25 | Sale | 196.22 | 500 | 98,110 | 0 | Sep 03 |
| SIEGERT PAUL ERIC | CO-CHAIRMAN | Aug 27 '25 | Sale | 199.95 | 40,000 | 7,998,000 | 0 | Aug 28 |
| Zucker Gillian Beth | Director | Jul 14 '25 | Sale | 191.65 | 200 | 38,330 | 5,533 | Jul 14 |
| GOLD IRWIN | CO-CHAIRMAN | Jun 30 '25 | Sale | 182.81 | 5,000 | 914,050 | 0 | Jun 30 |
| Zucker Gillian Beth | Director | Jun 13 '25 | Sale | 174.37 | 200 | 34,874 | 5,733 | Jun 13 |
| CRAIN CHRISTOPHER M | GENERAL COUNSEL | Jun 02 '25 | Sale | 173.02 | 500 | 86,510 | 0 | Jun 03 |
| BEISER SCOTT L | CO-CHAIRMAN | May 19 '25 | Sale | 178.71 | 8,008 | 1,431,110 | 0 | May 20 |
| Zucker Gillian Beth | Director | May 13 '25 | Sale | 178.46 | 200 | 35,692 | 5,201 | May 13 |